 |
- Injectable Kennel Cough Vaccine
- Bordetella bronchiseptica Bacterin
- 10 Dise Vial
|
|
|
|
 |
|
 |
|
Features
Bronchicine™CAe
Bordetella Bronchiseptica Bacterin
Cellular Antigen Extract
Description
Bronchicine™CAe is prepared from antigenic material extracted from the Bordetella bronchiseptica organism. A highly immunogenic strain of B. bronchiseptica is grown to a high yield, then subjected to a unique process which extracts the antigens from the Bordetella cells. The residual cell debris is then removed, resulting in a product which retains the desirable immunologic qualities of the whole cell, while reducing toxic and other undesirable side effects with whole cell bacterins.
Approved Uses
Bronchicine™CAe is approved for:
For the vaccination of normal, healthy puppies and dogs as an aid in the control of canine infectious tracheobronchitis (canine cough) caused by Bordetella bronchiseptica.
Key Features
The new formulation process significantly removes extraneous gram-negative cellular debris, proteinaceous material and lipopolysaccharides.
Convenient SC parenteral administration.
Ready to use, does not require reconstitution.
Non-adjuvanted, which minimizes local reactions.
Unique Cellular Antigen extraction process antigenic potency and minimizes potential for reactions.
Single antigen vaccine. Easily supplements vaccination programs and provides planned protection against canine cough.
New pack size: Now Available in 25x1 ds pack and 5x10 dose vial.
Packaging
A vial of liquid Bordetella bronchiseptica Bacterin.
Product Code 3322 25 x 1 dose (1mL) vials
Product Code 3331 5x 10 dose vial
Dosage and Administration
Injectable B. bronchiseptica vaccine.
Shake well. Administer 1 mL to healthy dogs at least 8 weeks of age. For initial vaccination, a second dose is required 2-4 weeks later. This product should be administered by subcutaneous injection only. Annual revaccination with a single 1 mL dose is recommended.
Suggested Vaccination Program
Puppies: Initial vaccination of puppies is recommended at 8 weeks of age.The effect of the presence of maternal antibodies to B. bronchiseptica upon the puppy’s ability to develop an active immune response has not been ascertained. However, puppies from immune bitches usually have low titers to B. bronchiseptica and this antibody usually disappears by the time the puppy is 4-6 weeks of age.
Adult Dogs: Dogs not previously vaccinated against B. bronchiseptica require two initial doses. Annual revaccination with a single 1 ml dose is recommended.
Precautions
Store at 35-45F (2-7C). Do not freeze. Use entire contents when first opened. Use aseptic technique. Care should be taken to avoid microbial contamination of the product. In case of anaphylactoid reactions, epinephrine should be administered immediately. Transient local irritation at the site of the injection, though rare, may occur subsequent to use of this product.Bronchicine™CAe
Bordetella Bronchiseptica Bacterin
Cellular Antigen Extract
|
|
|
 |
|
 |
|
|
|
